Dr Abraham elaborates on dealing with issues of infection, risks of malignancy, and pregnancy when caring for patients with Crohn disease.

Dr Dulai, from Northwestern University in Chicago, discusses the use of decision support tools to help clinicians choose and maximize therapies for patients with inflammatory bowel disease rather than trying to force an individual patient's circumstances into a set algorithm.

The frequency and severity of symptoms after a third mRNA vaccine dose were found to be generally similar or milder than after a second dose for most organ systems among patients with inflammatory bowel disease, a new study demonstrated.